ClassID:

97246

C07K2299/00 - page 3 - CPC Classification

Classification description:

Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Recent Application in this class:
#601
20070129895
2007-06-07

Crystal structure and uses thereof

#602
20070128709
2007-06-07

Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof

#603
20070124083
2007-05-31

Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)

#604
20070122411
2007-05-31

Solid forms of anti-EGFR antibodies

#605
20070105207
2007-05-10

Aggrecanase structure

#606
20070105085
2007-05-10

Crystal of a transporter-ligand complex and methods of use

#607
20070100560
2007-05-03

Crystal structures of MK2 and uses thereof

#608
20070099273
2007-05-03

Method for making β-secretase co-crystals complexed with a ligand

#609
20070099235
2007-05-03

Method for designing surfaces

#610
20070099232
2007-05-03

Ecdysone receptor ligand-binding domain structure

#611
20070093646
2007-04-26

Crystalline VAP-1 and uses thereof

#612
20070081973
2007-04-12

Cytokine polypeptides

#613
20070077641
2007-04-05

Methionine aminopeptidase and methods of use

#614
20070072791
2007-03-29

Glycogen synthase kinase-3 inhibitors

#615
20070072281
2007-03-29

Three-dimensional structure of the catalytic domain of protein kinase c theta, methods and uses thereof

#616
20070060740
2007-03-15

Protein crystal

#617
20070054846
2007-03-08

Bcl-w structure and uses therefor

#618
20070050152
2007-03-01

Protein Structure Determination

#619
20070048855
2007-03-01

Variants and chemically-modified variants of phenylalanine ammonia-lyase

#620
20070048853
2007-03-01

Carnitine palmitoyltransferase II crystals

#621
20070048791
2007-03-01

CRYSTAL STRUCTURES AND MODELS FOR Fc RECEPTORS AND USES THEREOF IN THE DESIGN OR IDENTIFICATION OF Fc RECEPTOR MODULATOR COMPOUNDS

#622
20070043208
2007-02-22

Crystal structure of erythrocyte binding domain of EBA-175

#623
20070042965
2007-02-22

Crystallized structure of type IV collagen NC1 domain hexamer

#624
20070042485
2007-02-22

Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein

#625
20070042353
2007-02-22

HCV polymerase suitable for crystal structure analysis and method for using the enzyme

#626
20070037217
2007-02-15

Structure-based selection and affinity maturation of antibody library

#627
20070037214
2007-02-15

Generation and selection of protein library in silico

#628
20070032640
2007-02-08

Cytokine receptor

#629
20070032637
2007-02-08

EGR-EGFR complex

#630
20070032403
2007-02-08

Crystal structure of the ITK kinase domain

#631
20070031956
2007-02-08

Crystal structure of human Pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design

#632
20070031849
2007-02-08

Three-dimensional structure of DNA recombination/repair protein and use thereof

#633
20070031401
2007-02-08

Catalytic domain of ADAM33 and methods of use thereof

#634
20070027215
2007-02-01

Nuclear receptor ligands and ligand binding domains

#635
20070026512
2007-02-01

Atomic structure of the catalytic domain for use in designing and identifying inhibitors of zap-70 kinase

#636
20070026500
2007-02-01

Crystalline Neutrokine-alpha protein, method of preparation thereof, and method of use thereof

#637
20070021917
2007-01-25

3-structure of a whole integrin $g(a) v$g(b) extracellular region and uses therefor

#638
20070021458
2007-01-25

Selective resonance of bodily agents

#639
20070021366
2007-01-25

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

#640
20070020745
2007-01-25

Method for crystallizing human GSK3 and novel crystal structure thereof

#641
20070020690
2007-01-25

Method for site-specific protein modifications

#642
20070020684
2007-01-25

Structure of a glucocorticoid receptor ligand binding domain comprising an expanded binding pocket and methods employing same

#643
20070020253
2007-01-25

Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof

#644
20070015906
2007-01-18

Essential fungal polynucleotides, polypeptides, and methods of use

#645
20070015695
2007-01-18

Three-dimensional structures of TALL-1 and its cognate receptors and modified proteins and methods related thereto

#646
20070015240
2007-01-18

Subtilases

#647
20070015205
2007-01-18

Crystal structure of phosphodiesterase 5 and use thereof

#648
20070010949
2007-01-11

Crystal structures of YHHF polypeptides

#649
20070010948
2007-01-11

G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model

#650
20070010540
2007-01-11

Crystal structure of liganded cFMS kinase domain

#651
20070009477
2007-01-11

PEGylated TNF-α variant proteins

#652
20070004020
2007-01-04

Crystal structures of aspartate semialdehyde dehydrogenases

#653
20070003976
2007-01-04

Car ligand-binding domain polypeptide co-crystallized with a ligand, and methods of designing ligands that modulate car activity

#654
20060293507
2006-12-28

Crystallization of IGF-1

#655
20060293286
2006-12-28

Resistant-repellent retroviral protease inhibitors

#656
20060287510
2006-12-21

Crystallization of IGF-1

#657
20060287235
2006-12-21

Crystallization of IGF-1

#658
20060281905
2006-12-14

Crystallization of IGF-1

#659
20060276397
2006-12-07

Crystallization of IGF-1

#660
20060275872
2006-12-07

Polynucleotide encoding a mutant transglutaminase

#661
20060275312
2006-12-07

Molecule

#662
20060270839
2006-11-30

Crystallization of IGF-1

#663
20060270836
2006-11-30

Crystallized structure of estrogen related receptor gamma in complex with bisphenol A

#664
20060258846
2006-11-16

Crystal structure of SNAP-25 in complex with botulinum neurotoxin and uses thereof

#665
20060258845
2006-11-16

Purified polypeptides from

#666
20060258737
2006-11-16

Resistance-repellent retroviral protease inhibitors

#667
20060246479
2006-11-02

Switch-region: target and method for inhibition of bacterial RNA polymerase

#668
20060241286
2006-10-26

Peptides for active anti-cytokine immunization

#669
20060241285
2006-10-26

Crystals and structure of Synagis Fab

#670
20060240465
2006-10-26

CNG2B: a novel human cyclic nucleotide-gated ion channel

#671
20060234906
2006-10-19

Structure of a complex of retinoblastoma protein bound to e2f, and uses thereof

#672
20060234293
2006-10-19

Polypeptide methods and means

#673
20060233804
2006-10-19

Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides

#674
20060229259
2006-10-12

AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

#675
20060223156
2006-10-05

Controlled dissolution crosslinked protein in crystals

#676
20060211040
2006-09-21

Crystal structure of chorismate synthase and uses thereof

#677
20060206269
2006-09-14

One-dimensional QSAR models

#678
20060194949
2006-08-31

Structure of the farnesoid X receptor ligand binding domain and methods of use therefor

#679
20060190186
2006-08-24

Viral polymerase and modulation thereof

#680
20060189540
2006-08-24

Peptides for diagnostic and therapeutic methods for celiac sprue

#681
20060188959
2006-08-24

Crystal structure of worm NitFhit reveals that a Nit tetramer binds tow Fhit dimers

#682
20060183196
2006-08-17

Polynucleotide encoding a novel cysteine protease of the calpain superfamily, CAN-12, and variants thereof

#683
20060178309
2006-08-10

Method for the crystallization of human serum albumin

#684
20060177871
2006-08-10

Murine IL-18 crystal structure

#685
20060177865
2006-08-10

Computational method for designing enzymes for incorporation of amino acid analogs into proteins

#686
20060174816
2006-08-10

Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof

#687
20060173633
2006-08-03

Crystalline phosphatase and method for use thereof

#688
20060160836
2006-07-20

Methods for the design of estrogen receptor ligands

#689
20060160726
2006-07-20

Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors

#690
20060160201
2006-07-20

Three-dimensional structures of HDAC9 and Cabin1 and compound structures and methods related thereto

#691
20060154868
2006-07-13

Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis

#692
20060154323
2006-07-13

Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes

#693
20060149033
2006-07-06

IGF antagonist peptides

#694
20060147973
2006-07-06

Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01

#695
20060147917
2006-07-06

Information processing system using base sequence relevant information

#696
20060142548
2006-06-29

Methods of identifying and designing cell surface receptor inhibitors

#697
20060141600
2006-06-29

Methods and compositions related to argonaute proteins

#698
20060141599
2006-06-29

Crystals of glucokinase and methods of growing them

#699
20060141456
2006-06-29

Methods and compositions for milieu-dependent binding of a targeted agent to a target

#700
20060136146
2006-06-22

MODULATORS OF RIBOSOMAL FUNCTION AND IDENTIFICATION THEREOF

#701
20060136141
2006-06-22

Method for crystallizing human beta secretase in complex with an inhibitor

#702
20060136136
2006-06-22

Crystal structure of baff, and use thereof in drug design

#703
20060134768
2006-06-22

Erbb4 co-crystal

#704
20060134767
2006-06-22

Mitotic kinesin binding site

#705
20060115837
2006-06-01

Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody

#706
20060115453
2006-06-01

Methods and compositions for treating cellular proliferative diseases

#707
20060110814
2006-05-25

Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase

#708
20060104935
2006-05-18

Controlled dissolution crosslinked protein crystals

#709
20060094100
2006-05-04

Structural models of carnitine acyltransferases and uses thereof

#710
20060094081
2006-05-04

Crystal structure of the c-fms kinase domain: applications and use of heterologous substitutions of kinase insert domains for crystallization

#711
20060088924
2006-04-27

ERK2 crystals

#712
20060079669
2006-04-13

Crystal structures of NH3-dependent NAD synthetases

#713
20060078977
2006-04-13

Novel purified polypeptides from Enterococcus faecalis

#714
20060078976
2006-04-13

Crystal structures of bacterial thymidylate kinases

#715
20060078974
2006-04-13

Novel purified hydroxymethylglutaryl-CoA reductases and structures thereof

#716
20060078922
2006-04-13

Novel purified polypeptides from haemophilus influenzae

#717
20060074222
2006-04-06

Determination of a phosphorylation site in PPIase domain of Pin1 and uses therefor

#718
20060074081
2006-04-06

Design of progesterone receptor ligands

#719
20060073582
2006-04-06

Rab9 protein crystal structures and methods for identifying Rab9 modulators

#720
20060073581
2006-04-06

Crystal structures of bacterial guanylate kinases

#721
20060069517
2006-03-30

Crystal structure of house dust mite allergen Der p 1

#722
20060069516
2006-03-30

Structure-based modulators of B1 G-protein coupled receptors

#723
20060069066
2006-03-30

Glycogen synthase kinase-3 inhibitors

#724
20060069019
2006-03-30

Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use

#725
20060063721
2006-03-23

AI-2 compounds and analogs based on LsrB structure

#726
20060063228
2006-03-23

Antibodies against human interleukin-13 and pharmaceutical compositions thereof

#727
20060063201
2006-03-23

Crystals of the Fc region of immunoglobulin epsilon heavy chain protein

#728
20060058510
2006-03-16

Anticalins

#729
20060052951
2006-03-09

Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1

#730
20060052941
2006-03-09

Crystal of bacterial core RNA polymerase and methods of use thereof

#731
20060036420
2006-02-16

Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof

#732
20060035294
2006-02-16

Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics

#733
20060030018
2006-02-09

Crystal structure of human JAK3 kinase domain complex and binding pockets thereof

#734
20060030017
2006-02-09

Three-dimensional structure of c-Abl

#735
20060030016
2006-02-09

Crystal structure of interleukin-2 tyrosine kinase (ITK) and binding pockets thereof

#736
20060024726
2006-02-02

Position dependent recognition of GNN nucleotide triplets by zinc fingers

#737
20060019349
2006-01-26

Position dependent recognition of GNN nucleotide triplets by zinc fingers

#738
20060014681
2006-01-19

Three-dimensional structure of complement receptor type 2 and uses thereof

#739
20060008532
2006-01-12

Complexes of protein crystals and ionic polymers

#740
20060003931
2006-01-05

Crystal structure of the hepatocyte growth factor and methods of use

#741
20060003432
2006-01-05

Novel purified polypeptides from enterococcus faecalis

#742
20060003431
2006-01-05

Structure of protein kinase C theta

#743
20050287170
2005-12-29

Subunit vaccine against West Nile viral infection

#744
20050272924
2005-12-08

Cold shock inducible expression and production of heterologous polypeptides

#745
20050272681
2005-12-08

Ribosome structure and protein synthesis inhibitors

#746
20050272114
2005-12-08

Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule

#747
20050261836
2005-11-24

Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof

#748
20050260732
2005-11-24

Three-dimensional structure of dipeptidyl peptidase IV

#749
20050260727
2005-11-24

Crystal structure of the mitochondrial protoporphyrinogen IX oxidase

#750
20050260154
2005-11-24

Modified G-CSF polypeptide

#751
20050256054
2005-11-17

Drug therapy for celiac sprue

#752
20050255576
2005-11-17

Three-dimensional structure of prostaglandin D synthase and utilization thereof

#753
20050245728
2005-11-03

Novel purified polypeptides from Pseudomonas aeruginosa

#754
20050244939
2005-11-03

Variant aldolase and processes for producing an optically active IHOG and an optically active monatin using the same

#755
20050239186
2005-10-27

Peptidyl-tRNA hydrolase of Enterococcus faecalis

#756
20050239140
2005-10-27

Solution phase biopanning method using engineered decoy proteins

#757
20050234227
2005-10-20

Ribosome structure and protein synthesis inhibitors

#758
20050233371
2005-10-20

Human cyclic nucleotide-gated cation channel polypeptide

#759
20050233349
2005-10-20

Crystal structure of ribosomal protein L11/GTPase activating region rRNA and uses thereof

#760
20050226892
2005-10-13

Methods and compositions comprising bacteriophage nanoparticles

#761
20050221462
2005-10-06

Novel purified polypeptides from pseudomonas aeruginosa

#762
20050221285
2005-10-06

Method for identifying or screening anti-viral agents

#763
20050215477
2005-09-29

Crystallization of IGF-1

#764
20050214918
2005-09-29

Novel purified polypeptides from streptococcus pneumoniae

#765
20050214845
2005-09-29

Small and intermediate conductance, calcium-activated potassium channels and uses thereof

#766
20050214773
2005-09-29

Novel purified polypeptides from bacteria

#767
20050209837
2005-09-22

Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling or related proteins

#768
20050208639
2005-09-22

Crystal structure of staphylococcus undecaprenyl pyrophosphate synthase and uses thereof

#769
20050208620
2005-09-22

Compositions and methods for hydroxylating epothilones

#770
20050208587
2005-09-22

Peptides that bind to broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex. uses thereof, compositions therefrom

#771
20050208490
2005-09-22

Ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3) and uses thereof

#772
20050208463
2005-09-22

Method of screening drug

#773
20050202550
2005-09-15

Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof

#774
20050202549
2005-09-15

Crystal structure

#775
20050202548
2005-09-15

Crystalline structure of oxidosqualene synthase

#776
20050197492
2005-09-08

Crystal structure of VEGFRKD: ligand complexes and methods of use thereof

#777
20050196851
2005-09-08

Crystal structure of the BTK kinase domain

#778
20050196808
2005-09-08

Products and processes for modulating peptide-peptide binding domain interactions

#779
20050187718
2005-08-25

Novel purified polypeptides from Streptococcus pneumoniae

#780
20050187716
2005-08-25

Three-dimensional model of a Fc region of an IgE antibody and uses thereof

#781
20050187150
2005-08-25

Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds

#782
20050186636
2005-08-25

Method of rational-based drug design using osteocalcin

#783
20050181975
2005-08-18

Crystal structure of FMS-like tyrosine kinase

#784
20050181362
2005-08-18

Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same

#785
20050176060
2005-08-11

Crystal structure

#786
20050171000
2005-08-04

Three dimensional coordinates of melanocortin-4 receptors

#787
20050170433
2005-08-04

Three dimensional coordinates of melanin-concentrating hormone receptors

#788
20050170431
2005-08-04

PYK2 crystal structure and uses

#789
20050170337
2005-08-04

Oligomerization of hepatitis delta antigen

#790
20050165218
2005-07-28

Crystal structure of the ligand binding domain of the retinoic acid-related orphan receptor alpha (ror-alpha)

#791
20050164363
2005-07-28

Novel purified polypeptides from staphylococcus aureus

#792
20050164362
2005-07-28

Novel purified polypeptides from pseudomonas aeruginosa

#793
20050159901
2005-07-21

Crystal structure of cytochrome P450

#794
20050158732
2005-07-21

Novel purified polypeptides from Streptococcus pneumoniae

#795
20050154538
2005-07-14

Crystal structure of the 30S ribosome and its use

#796
20050154229
2005-07-14

Maleic acid salt of(2s)-n-{5-[amino(imino)methy]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]-3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for

#797
20050148030
2005-07-07

Inhibition of immune complex formation

#798
20050148001
2005-07-07

Structure-based construction of human antibody library

#799
20050143926
2005-06-30

Method and apparatus for generating biologically-active-substance candidate structure, and computer product

#800
20050143402
2005-06-30

Crystal structure of aurora-2 protein and binding pockets thereof

#801
20050131209
2005-06-16

Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same

#802
20050124542
2005-06-09

Crystallisation of a GLP-1 analogue

#803
20050114109
2005-05-26

STRUCTURE OF INTEGRIN ALPHA V-beta 3 EXTRACELLULAR DOMAIN COMPLEXED WITH LIGAND

#804
20050114037
2005-05-26

Methods for rational pegylation of proteins

#805
20050113309
2005-05-26

Crystalline forms(2s)-n-5[amino(imino)methyl]-2-thienylmethyl-1-(2r)-2[(carboxymethyl) amino]-3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o

#806
20050112746
2005-05-26

Crystals and structures of protein kinase CHK2

#807
20050112683
2005-05-26

Methods and apparatus for protein sequence analysis

#808
20050107342
2005-05-19

Resistance-repellent retroviral protease inhibitors

#809
20050107298
2005-05-19

Crystals and structures of c-Abl tyrosine kinase domain

#810
20050095247
2005-05-05

Diagnosis and treatment of infectious diseases through indel-differentiated proteins

#811
20050085626
2005-04-21

Polo domain structure

#812
20050075795
2005-04-07

Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE1B) and uses thereof

#813
20050059085
2005-03-17

Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof

#814
20050048573
2005-03-03

PDE5A crystal structure and uses

#815
20050038611
2005-02-17

S8 rRNA-binding protein from the small ribosomal subunit of

#816
20050037478
2005-02-17

Crystal structure of glutamate racemase (MurI)

#817
20050037476
2005-02-17

Modified Wee1, crystals of peptide: inhibitor complexes containing such modified Wee1, and methods of use thereof

#818
20050037383
2005-02-17

Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof

#819
20050036997
2005-02-17

Method of identifying molecules that bind to the large ribosomal subunit

#820
20050033035
2005-02-10

Mutants of igf binding proteins and methods of production of antagonists thereof

#821
20050032119
2005-02-10

Crystal structure of cytochrome P450

#822
20050015232
2005-01-20

Computer-based methods of designing molecules

#823
20050010368
2005-01-13

Method for the prediction of binding targets and the design of ligands

#824
20050009163
2005-01-13

Carboxyltransferase domain of acetyl-CoA carboxylase

#825
20050003502
2005-01-06

Structures and methods for designing topoisomerase I inhibitors

#826
20050003348
2005-01-06

Hepatitis C Virus NS5B polymerase inhibitor binding pocket

#827
20050002898
2005-01-06

N-TRADD active site and uses thereof

#828
14479735
2015-11-10

C.difficile toxin B CROP domain peptides, antibodies and complexes thereof

#829
10749962
2016-06-28

Human growth hormone crystals and methods for preparing them